Contribute
España
Italia
대한민국
日本
Français
Benzinga
Research
My Stocks
Tools
Free Benzinga Pro Trial

Pfizer

Pfizer is an American multinational pharmaceutical corporation founded in 1849 and headquartered in New York City. The company is known for developing and manufacturing a wide range of medicines and vaccines, including treatments for cardiovascular, oncology, and infectious diseases. Pfizer played a key role in producing one of the first widely distributed COVID-19 vaccines in partnership with BioNTech. Its research and development efforts focus on advancing innovative therapies to address global health challenges.

Cathie Wood's Ark Invest Dumps Over $9M In Moderna Stock — Even With Post-COVID Plans On The Table
Cathie Wood's Ark Invest Dumps Over $9M In Moderna Stock — Even With Post-COVID Plans On The Table
Pfizer Initiates Multi-Year Cost Reduction Plan Targeting $1.5B Savings By 2027
Pfizer Initiates Multi-Year Cost Reduction Plan Targeting $1.5B Savings By 2027
16-Minute Gene Therapy Restores Hearing To British Baby, A World First
16-Minute Gene Therapy Restores Hearing To British Baby, A World First
Pfizer Initiates Multi-Year Cost Reduction Plan Targeting $1.5B Savings By 2027
Pfizer Initiates Multi-Year Cost Reduction Plan Targeting $1.5B Savings By 2027
16-Minute Gene Therapy Restores Hearing To British Baby, A World First
16-Minute Gene Therapy Restores Hearing To British Baby, A World First
Carvana, Enovix, Pfizer, Nio, Tesla: Why These 5 Stocks Are On Investors' Radars Today
Carvana, Enovix, Pfizer, Nio, Tesla: Why These 5 Stocks Are On Investors' Radars Today
CDC Urges Second COVID-19 Vaccine Dose For Elderly Americans Amid Rising Hospitalizations
CDC Urges Second COVID-19 Vaccine Dose For Elderly Americans Amid Rising Hospitalizations

Pfizer Recent News

Apple, Adobe, Pfizer, Alibaba, Tesla: Why These 5 Stocks Are On Investors' Radars Today
Apple, Adobe, Pfizer, Alibaba, Tesla: Why These 5 Stocks Are On Investors' Radars Today
Major U.S. indices were in the green on Wednesday with the Dow Jones rising 1.4% to 37,090.24, the S&P 500 gaining 1.37% to 4,707.09.
Voicing Opinions On Israel-Hamas Conflict: A Double-edged Sword For Businesses
Voicing Opinions On Israel-Hamas Conflict: A Double-edged Sword For Businesses
According to an Associated Press report, the Israel-Hamas conflict has stirred up controversy within the global business sector.
Tesla, Oracle, Novavax, DraftKings, Pfizer: Why These Five Stocks Are Trending Today
Tesla, Oracle, Novavax, DraftKings, Pfizer: Why These Five Stocks Are Trending Today
U.S. stocks showcased a positive momentum as the trading day approached its end. The Nasdaq Composite exhibited a notable rise, gaining more than 1% on Monday.
European Regulator Expands Ozempic Probe To Include Other Weight Loss Drugs Over Suicide Risks
European Regulator Expands Ozempic Probe To Include Other Weight Loss Drugs Over Suicide Risks
Zoetis Declares New Dividend, Hinting At Undervaluation
Zoetis Declares New Dividend, Hinting At Undervaluation
Zoetis (NYSE: ZTS) shareholders may have a new reference point to be excited about, even after witnessing some favorable developments through the company's first quarter 2023 announcements.
Recently Revealed Pfizer Collaboration Might Just Be What The Doctor Ordered For TFF Pharmaceuticals
Recently Revealed Pfizer Collaboration Might Just Be What The Doctor Ordered For TFF Pharmaceuticals
By StoryTrading Pfizer collaboration just revealed in presentation update - no PR issued yet! – Several near-term catalysts possible, including further partnerships with big pharma – Sentiment: CEO’s credibility hit from under-delivering now turning around 
Boosters And Mandate Could Increase Vaccine Demand
Boosters And Mandate Could Increase Vaccine Demand
This is an excerpt from Medically Necessary, a health care supply chain newsletter. Subscribe here.
Partner Content
This Cancer Screening Company Has A Better 5-Year Return Than Pfizer, Johnson & Johnson And Gilead
This Cancer Screening Company Has A Better 5-Year Return Than Pfizer, Johnson & Johnson And Gilead
Small-cap stocks have a history of outperforming large-cap names as they have the potential for rapid growth and have event-driven moves for share prices. A company focused on cancer screening and diagnostic tests has outperformed some of the largest healthcare companies over the last five years and went from small-cap to a market cap of more than $18 billion.
Moderna Boosters Might Not Be Ready By Sept 20, Pfizer On Track: Fauci
Moderna Boosters Might Not Be Ready By Sept 20, Pfizer On Track: Fauci
On Sunday, President Joe Biden's Chief Medical Adviser Dr. Anthony Fauci said officials would soon get the regulatory clearance to administer Covid-19 vaccine booster shots made by Pfizer Inc (NYSE: PFE).
Airbnb Did Not Deliver Vaccines- But It Is Just As Much Of A Hero
Airbnb Did Not Deliver Vaccines- But It Is Just As Much Of A Hero
Last week, Reuters reported that Airbnb (NASDAQ: ABNB) has offered to provide free, temporary housing to 20,000 Afghan refugees across the globe, helping its shares close up 10% after the announcement.
Partner Content
Benzinga's Bulls And Bears Of The Past Week: Alibaba, Bitcoin, Pfizer, Tesla And More
Benzinga's Bulls And Bears Of The Past Week: Alibaba, Bitcoin, Pfizer, Tesla And More
Benzinga has examined the prospects for many investor favorite stocks over the past week. Last week's bullish calls included a top COVID-19 vaccine play, a recent high-profile IPO and a trendy retailer.
Strong Crude, Higher Yields, Best Buy Earnings Combine To Give Market Early Lift
Strong Crude, Higher Yields, Best Buy Earnings Combine To Give Market Early Lift
After another big rally to start the week, what can Wall Street do for an encore?  Maybe not a lot, at least for the moment. Stocks moved up just a bit in pre-market trading. It looks early like there might be a chance for small gains on top of what happened yesterday, but a lack of major new developments may keep things on a simmer. 
Partner Content
BioMedNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Receives FDA Clearance For mmRNA Oral Appliance
BioMedNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Receives FDA Clearance For mmRNA Oral Appliance
The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga.
Partner Content
The Latest Barron's Picks And Pans: Facebook, Jefferies, Palantir, Spotify And More
The Latest Barron's Picks And Pans: Facebook, Jefferies, Palantir, Spotify And More
This weekend's Barron's cover story examines the long-term prospects for big tech companies currently in the sights of regulators and lawmakers.
Benzinga's Bulls And Bears Of The Week: Apple, Coinbase, Starbucks, Virgin Galactic, Walmart And More
Benzinga's Bulls And Bears Of The Week: Apple, Coinbase, Starbucks, Virgin Galactic, Walmart And More
Benzinga has examined the prospects for many investor favorite stocks over the past week. Last week's bullish calls included top growth and reopening stocks. Automakers and a leading cryptocurrency play were among the bearish calls seen.
Barron's Most Recent Picks And Pans: Airbnb, Duke Energy, Evoqua, Netflix And More
Barron's Most Recent Picks And Pans: Airbnb, Duke Energy, Evoqua, Netflix And More
The cover story in this weekend's Barron's suggests how to play travel stocks as the recovery falters. Other featured articles discuss banking stocks with steady dividends, stocks that will benefit from share buybacks and why the boom in energy stocks may be over.
The Vaccine Club- Fall Will Be The Ultimate Test
The Vaccine Club- Fall Will Be The Ultimate Test
Partner Content
Benzinga's Bulls And Bears Of The Week: Apple, Amazon, Kroger, Netflix, Pfizer And More
Benzinga's Bulls And Bears Of The Week: Apple, Amazon, Kroger, Netflix, Pfizer And More
Benzinga has examined the prospects for many of investors' favorite stocks over the past week. The past week's bullish calls included a couple of FAANG stocks and a company that just took a big hit.
Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved